Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02099227
Other study ID # AHC IRB 5577
Secondary ID
Status Completed
Phase N/A
First received March 26, 2014
Last updated September 8, 2016
Start date March 2014
Est. completion date September 2015

Study information

Verified date September 2016
Source Advocate Health Care
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review BoardUnited States: Food and Drug Administration
Study type Observational

Clinical Trial Summary

To examine the effect of Point-of-Care Ultrasound (POCUS) management guidance on pediatric skin and soft tissue infections treatment failure rate, as well as emergency department process outcome.


Recruitment information / eligibility

Status Completed
Enrollment 280
Est. completion date September 2015
Est. primary completion date September 2015
Accepts healthy volunteers No
Gender Both
Age group 6 Months to 19 Years
Eligibility Inclusion Criteria:

- history and examination findings consistent with possible abscess or cellulitis per the treating clinician.

- minimal lesion diameter for inclusion is 1cm.

Exclusion Criteria:

- suspected soft tissue infections involving or near mucosal membranes (e.g. perirectal, peritonsillar, vulvovaginal areas)

- facial lesions

- paronychia or felon

- parent or patient refusal of consent

- unsuitable subjects deemed by treating clinicians.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Locations

Country Name City State
United States Advocate Christ Medical Center Oak Lawn Illinois

Sponsors (7)

Lead Sponsor Collaborator
May Alrahi American College of Emergency Physicians, Children's Hospital & Research Center Oakland, Maimonides Medical Center, Montefiore Medical Center, Newark Beth Israel Medical Center, Texas Children's Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary treatment failure rate unscheduled return visits need for subsequent procedural intervention need for subsequent admission change in therapy 7-10days No
Secondary emergency department process outcome emergency department (ED) length of stay, need for ED procedural sedation use of alternative imaging in ED 7-10days No
See also
  Status Clinical Trial Phase
Completed NCT00658866 - Target Site Pharmacokinetics of Ertapenem After Multiple Doses in Diabetes Patients With Soft Tissue Infection Phase 4